Literature DB >> 1580252

Occupational exposure to carcinogens in Finland.

P Heikkilä1, T Kauppinen.   

Abstract

Finland has kept a registry on the manufacture and use of carcinogenic agents involving occupational exposure since 1979. Employers must report annually to the labor safety authorities the employees who have been exposed to carcinogens and provide information on carcinogenic agents produced, used, or formed. Out of 131 substances or groups of agents listed as carcinogenic, occupational exposure to 78 of them was reported in 1987. About half of the agents reported were used or produced in industry and half were handled on a laboratory scale. About 15,000 employees from 1,700 work departments were reported to the registry; 17% of them were women. The number of workers reported in 1987 accounted for 0.6% of the total work force. It has been estimated that at least 60,000 workers are exposed annually to carcinogens in Finland. The three most prevalent exposures--hexavalent chromium compounds, nickel and its inorganic compounds, and asbestos--accounted for over 60% of all exposed workers; only five carcinogenic chemicals were produced in Finland in 1987.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1580252     DOI: 10.1002/ajim.4700210403

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  3 in total

1.  Comment: Toward a coordinated system for the surveillance of environmental health hazards.

Authors:  I Hertz-Picciotto
Journal:  Am J Public Health       Date:  1996-05       Impact factor: 9.308

2.  Use of a crop and job specific exposure matrix for retrospective assessment of long-term exposure in studies of chronic neurotoxic effects of agrichemicals.

Authors:  L London; J E Myers
Journal:  Occup Environ Med       Date:  1998-03       Impact factor: 4.402

Review 3.  Polycyclic aromatic hydrocarbons and cancer in man.

Authors:  G Mastrangelo; E Fadda; V Marzia
Journal:  Environ Health Perspect       Date:  1996-11       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.